IHAM
JAZZ icon

Integral Health Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Integral Health Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.23M Buy
+30,000
New +$6.57M 0.29% 70
2022
Q3 		– Sell
-20,874
Closed -$3.26M – 72
2022
Q2 		$3.26M Sell
20,874
-14,126
-40% -$2.17M 0.67% 48
2022
Q1 		$5.45M Buy
+35,000
New +$5.08M 1.42% 29

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Integral Health Asset Management's JAZZ Position: Q2 2026 in Review

Integral Health Asset Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 30,000 shares worth $7.23M. The stake represents 0.29% of the portfolio and ranks #70 among its holdings. This is a return to the name: Integral Health Asset Management previously reported a position in JAZZ as recently as Q2 2022.

Integral Health Asset Management first reported a position in JAZZ in Q1 2022 and has held it in 3 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Integral Health Asset Management held 30,000 shares of Jazz Pharmaceuticals worth $7.23M as of Q2 2026.
  • Jazz Pharmaceuticals was a new Integral Health Asset Management position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.29% of Integral Health Asset Management's portfolio in Q2 2026, its #70 holding.
  • Integral Health Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2022 and has held it in 3 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.